Inventor · disambiguated record
Klaus G. Klumpp
Also filed as: KLUMPP KLAUS · KLUMPP KLAUS G
13 granted patents·10 pending applications·105 citations·filing 2006–2024
89Inventor score
Files withRIBOSCIENCE LLC17NOVIRA THERAPEUTICS INC2BILOTTA JOSEPH A1HOFFMANN LA ROCHE1JAVANBAKHT HASSAN1
Top patents by PatentIndex Score
23 records- 0196US7608599B2Antiviral phosphoramidatesROCHE PALO ALTO LLC·Filed 2006·Granted Oct 27, 2009·76 cites·13 claims
- 0288US9370569B24′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationRIBOSCIENCE LLC·Filed 2015·Granted Jun 21, 2016·8 cites·20 claims
- 0386US9249176B24′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2014·Granted Feb 2, 2016·9 cites·20 claims
- 0484US10953030B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2019·Granted Mar 23, 2021·1 cites·15 claims
- 0583US11351186B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2020·Granted Jun 7, 2022·1 cites·14 claims
- 0681US10682369B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2018·Granted Jun 16, 2020·1 cites·22 claims
- 0781US10092649B24′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replicationRIBOSCIENCE LLC·Filed 2016·Granted Oct 9, 2018·3 cites·19 claims
- 0880US10441589B2Combinations and methods comprising a capsid assembly inhibitorNOVIRA THERAPEUTICS INC·Filed 2017·Granted Oct 15, 2019·4 cites·4 claims
- 0973US9895442B24′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2014·Granted Feb 20, 2018·2 cites·24 claims
- 1072US2025041319A1Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 1167US2021369755A14'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA ReplicationRIBOSCIENCE LLC·Filed 2021·Application pending·0 cites
- 1266US11129834B2Combinations and methods comprising a capsid assembly inhibitorNOVIRA THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·0 cites·2 claims
- 1363US12029744B2Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2020·Granted Jul 9, 2024·0 cites·40 claims
- 1462US2018200280A14'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA ReplicationRIBOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 1558US2014010783A1Antiviral compoundsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1648US2022056052A1Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitorsRIBOSCIENCE LLC·Filed 2019·Application pending·0 cites
- 1747US2013018011A1Method of treating dengue feverJAVANBAKHT HASSAN·Filed 2012·Application pending·0 cites
- 1845US9694028B24′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replicationRIBOSCIENCE LLC·Filed 2016·Granted Jul 4, 2017·0 cites·20 claims
- 1941US2016168186A1Method of Treating Dengue FeverRIBOSCIENCE LLC·Filed 2015·Application pending·0 cites
- 2041US2015307461A1Antiviral compoundsBILOTTA JOSEPH A·Filed 2015·Application pending·0 cites
- 2139US2017232031A1Inhibitors of Zika VirusRIBOSCIENCE LLC·Filed 2017·Application pending·0 cites
- 2237US10358458B24′-vinyl substituted nucleoside derivatives as inhibitors of respiratory syncytial virus RNA replicationRIBOSCIENCE LLC·Filed 2015·Granted Jul 23, 2019·0 cites·15 claims
- 2337US2016237106A14'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replicationRIBOSCIENCE LLC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →